Xiaoyang Li

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Histone Deacetylase

Top Venues

Journal of medicinal chemistry

Medicinal research reviews

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Wanting Hao, Dong-Dong Luo, Yuqi Jiang, Shengbiao Wan, Xiaoyang Li
An overview of sphingosine-1-phosphate receptor 2: Structure, biological function, and small-molecule modulators. Medicinal research reviews 44 (5) (2024)
Wanting Hao, Leyan Wang, Tongqiang Xu, Geng Jia, Yuqi Jiang, Chong Qin, Xiaoyang Li
Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax. Marine drugs 22 (6) (2024)
Wanting Hao, Leyan Wang, Tongqiang Xu, Geng Jia, Yuqi Jiang, Chong Qin, Xiaoyang Li
Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax. Marine drugs 22 (6) (2024)
Wanting Hao, Dong-Dong Luo, Yuqi Jiang, Shengbiao Wan, Xiaoyang Li
An overview of sphingosine-1-phosphate receptor 2: Structure, biological function, and small-molecule modulators. Medicinal research reviews 44 (5) (2024)
Wanting Hao, Leyan Wang, Tongqiang Xu, Geng Jia, Yuqi Jiang, Chong Qin, Xiaoyang Li
Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax. Marine drugs 22 (6) (2024)
Wanting Hao, Dong-Dong Luo, Yuqi Jiang, Shengbiao Wan, Xiaoyang Li
An overview of sphingosine-1-phosphate receptor 2: Structure, biological function, and small-molecule modulators. Medicinal research reviews (2024)
Liang Zhang, Kangjing Qi, Jie Xu, Yan Xing, Xuejian Wang, Ling Tong, Zengguo He, Wenfang Xu, Xiaoyang Li, Yuqi Jiang
Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine. Journal of medicinal chemistry 66 (6) (2023)
Liang Zhang, Kangjing Qi, Jie Xu, Yan Xing, Xuejian Wang, Ling Tong, Zengguo He, Wenfang Xu, Xiaoyang Li, Yuqi Jiang
Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine. Journal of medicinal chemistry 66 (6) (2023)
Liang Zhang, Kangjing Qi, Jie Xu, Yan Xing, Xuejian Wang, Ling Tong, Zengguo He, Wenfang Xu, Xiaoyang Li, Yuqi Jiang
Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine. Journal of medicinal chemistry (2023)
Jian Zhang, Simin Sun, Jinyu Liu, Liang Zhang, Di Guo, Naixin Zhang, Jun Zhao, Dexin Kong, Tongqiang Xu, Xuejian Wang, Wenfang Xu, Xiaoyang Li, Yuqi Jiang
Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer. Molecules (Basel, Switzerland) 28 (17) (2023)
Zhuoyue Li, Yiming Chen, Xiaolin Jiang, Penghui Lu, Chengli Wang, Zhimin Li, Xinyue Yu, Zixuan Yang, Shumin Ma, Shanshan Du, Zhengfu Tai, Xiaoyang Li, Siqi Zhang, Yuqi Jiang, Chong Qin
Novel Sulfonylurea-Based NLRP3 Inflammasome Inhibitor for Efficient Treatment of Nonalcoholic Steatohepatitis, Endotoxic Shock, and Colitis. Journal of medicinal chemistry (2023)
Dongdong Luo, Xiaochun Liu, Leilei Jiang, Zhikun Guo, Yan Lv, Xiaochen Tian, Xiaoyan Wang, Shuxiang Cui, Sheng-Biao Wan, Ximing Xu, Xiaoyang Li, Xianjun Qu
Correction to "Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer". Journal of medicinal chemistry 65 (23) (2022)
Dongdong Luo, Xiaochun Liu, Leilei Jiang, Zhikun Guo, Yan Lv, Xiaochen Tian, Xiaoyan Wang, Shuxiang Cui, Sheng-Biao Wan, Xianjun Qu, Ximing Xu, Xiaoyang Li
Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer. Journal of medicinal chemistry 65 (21) (2022)
Kairui Yue, Simin Sun, Geng Jia, Mengting Qin, Xiaohan Hou, C James Chou, Chao Huang, Xiaoyang Li
First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation. Journal of medicinal chemistry 65 (18) (2022)
Yuqi Jiang, Jie Xu, Kairui Yue, Chao Huang, Mengting Qin, Dongyu Chi, Qixin Yu, Yue Zhu, Xiaohan Hou, Tongqiang Xu, Min Li, C James Chou, Xiaoyang Li
Potent Hydrazide-Based HDAC Inhibitors with a Superior Pharmacokinetic Profile for Efficient Treatment of Acute Myeloid Leukemia In Vivo. Journal of medicinal chemistry 65 (1) (2021)
Xiaoyang Li, Richard A Himes, Lyndsey C Prosser, Charleston F Christie, Emma Watt, Sharon F Edwards, Cameron S Metcalf, Peter J West, Karen S Wilcox, Sherine S L Chan, C James Chou
Discovery of the First Vitamin K Analogue as a Potential Treatment of Pharmacoresistant Seizures. Journal of medicinal chemistry 63 (11) (2020)
Xiaoyang Li, Yuqi Jiang, Yuri K Peterson, Tongqiang Xu, Richard A Himes, Xin Luo, Guilin Yin, Elizabeth S Inks, Nathan Dolloff, Stephanie Halene, Sherine S L Chan, C James Chou
Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity. Journal of medicinal chemistry 63 (10) (2020)
Xuewu Liang, Jie Zang, Xiaoyang Li, Shuai Tang, Min Huang, Meiyu Geng, C James Chou, Chunpu Li, Yichun Cao, Wenfang Xu, Hong Liu, Yingjie Zhang
Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies. Journal of medicinal chemistry 62 (8) (2019)
Jie Zang, Xuewu Liang, Yongxue Huang, Yuping Jia, Xiaoyang Li, Wenfang Xu, C James Chou, Yingjie Zhang
Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously. Journal of medicinal chemistry 61 (12) (2018)
Xiaoyang Li, Yuri K Peterson, Elizabeth S Inks, Richard A Himes, Jiaying Li, Yingjie Zhang, Xiujie Kong, C James Chou
Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status. Journal of medicinal chemistry 61 (6) (2018)